Ossiam’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $108M | Buy |
+90,300
| New | +$92.3M | 1.44% | 14 |
|
|
2025
Q4 | – | Sell |
-25,018
| Closed | -$19.1M | – | 553 |
|
|
2025
Q3 | $19.1M | Sell |
25,018
-30,647
| -55% | -$22.8M | 0.25% | 78 |
|
|
2025
Q2 | $43.4M | Sell |
55,665
-222,285
| -80% | -$173M | 0.49% | 44 |
|
|
2025
Q1 | $230M | Buy |
277,950
+204,502
| +278% | +$170M | 3.21% | 8 |
|
|
2024
Q4 | $56.7M | Sell |
73,448
-98,552
| -57% | -$81.6M | 0.98% | 23 |
|
|
2024
Q3 | $152M | Buy |
172,000
+97,824
| +132% | +$87.9M | 2.95% | 6 |
|
|
2024
Q2 | $67.2M | Sell |
74,176
-16,499
| -18% | -$13.2M | 1.27% | 18 |
|
|
2024
Q1 | $70.5M | Buy |
90,675
+20,046
| +28% | +$14.3M | 1.24% | 22 |
|
|
2023
Q4 | $41.2M | Sell |
70,629
-38,495
| -35% | -$22.5M | 0.66% | 37 |
|
|
2023
Q3 | $58.6M | Sell |
109,124
-102,453
| -48% | -$52.8M | 1.04% | 20 |
|
|
2023
Q2 | $99.2M | Buy |
211,577
+83,982
| +66% | +$35.2M | 1.78% | 13 |
|
|
2023
Q1 | $43.8M | Buy |
127,595
+55,119
| +76% | +$18.6M | 0.91% | 29 |
|
|
2022
Q4 | $26.5M | Buy |
72,476
+65,696
| +969% | +$23.3M | 0.69% | 42 |
|
|
2022
Q3 | $2.19M | Buy |
6,780
+6,659
| +5,503% | +$2.11M | 0.06% | 179 |
|
|
2022
Q2 | $39K | Sell |
121
-26,691
| -100% | -$8.01M | ﹤0.01% | 388 |
|
|
2022
Q1 | $7.68M | Buy |
26,812
+3,028
| +13% | +$779K | 0.2% | 82 |
|
|
2021
Q4 | $6.57M | Buy |
23,784
+1,259
| +6% | +$319K | 0.17% | 101 |
|
|
2021
Q3 | $5.2M | Buy |
22,525
+4,188
| +23% | +$1.03M | 0.15% | 108 |
|
|
2021
Q2 | $4.46M | Sell |
18,337
-2,954
| -14% | -$593K | 0.12% | 115 |
|
|
2021
Q1 | $3.98M | Sell |
21,291
-24,128
| -53% | -$4.72M | 0.12% | 120 |
|
|
2020
Q4 | $7.67M | Buy |
45,419
+44,343
| +4,121% | +$6.62M | 0.27% | 80 |
|
|
2020
Q3 | $159K | Sell |
1,076
-3,129
| -74% | -$484K | 0.01% | 346 |
|
|
2020
Q2 | $690K | Sell |
4,205
-3,432
| -45% | -$527K | 0.04% | 194 |
|
|
2020
Q1 | $1.06M | Buy |
7,637
+6,610
| +644% | +$908K | 0.07% | 171 |
|
|
2019
Q4 | $135K | Sell |
1,027
-25,978
| -96% | -$3.01M | 0.01% | 352 |
|
|
2019
Q3 | $3.02M | Buy |
27,005
+26,346
| +3,998% | +$2.93M | 0.21% | 89 |
|
|
2019
Q2 | $73K | Buy |
+659
| New | +$77.6K | 0.01% | 395 |
|
|
2019
Q1 | – | Sell |
-8,586
| Closed | -$994K | – | 307 |
|
|
2018
Q4 | $994K | Buy |
+8,586
| New | +$959K | 0.15% | 114 |
|
Other funds holding LLY
Ossiam's LLY Position: Q2 2026 in Review
Ossiam opened a new position in Eli Lilly (LLY) in Q2 2026: 90,300 shares worth $108M. The stake represents 1.44% of the portfolio and ranks #14 among its holdings. This is a return to the name: Ossiam previously reported a position in LLY as recently as Q3 2025.
Ossiam first reported a position in LLY in Q4 2018 and has held it in 28 quarters since. The position peaked at $230M in Q1 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Ossiam held 90,300 shares of Eli Lilly worth $108M as of Q2 2026.
- Eli Lilly was a new Ossiam position in Q2 2026.
- Eli Lilly made up 1.44% of Ossiam's portfolio in Q2 2026, its #14 holding.
- Ossiam first reported a position in Eli Lilly in Q4 2018 and has held it in 28 quarters since.
- Ossiam's Eli Lilly position peaked at $230M in Q1 2025.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.